The Food and Drug Administration is
requiring nine companies to conduct a post market study on positive
displacement needleless connectors to determine whether they may be associated
with a higher rate of device-associated bloodstream infections (BSI) than other
types of needleless connectors, and to assess the factors that may contribute
to a possible increased risk. "As of today, there have been five companies to recall their products leaving four left to decide to remake or stop production on their products."4
FDA has received three reports of death
associated with BSI and positive displacement needleless connectors. Infection
control authorities are also concerned about positive displacement connectors
and the device’s association with BSI.
There
have been several clinical reports since 2006showing the association between
the introduction of positive displacement needleless connectors into a hospital
or unit and an increased rate of BSI, followed by a reduction in BSI after
changing to another type of needleless connector. However, because there is insufficient
information to determine if positive displacement connectors increase the risk
of BSI compared with other needleless connectors, FDA is requiring the
companies to conduct post market studies to provide an assessment of the risk
associated with positive displacement needleless connectors.
“In 2011 a survey
sent to 4,000 health care workers in clinical practice found that 132 (25.4%)
of the 554 respondents did not know the specific type of needleless connector
they used with short peripheral catheters and 114 (21.9%) did not know the type
they used with central venous catheters, and nearly half of respondents
didn't understand the correct way to flush and clamp a catheter with a
needleless connector attached, even though it's essential to device
performance. Self-reported practices are not the best methods by which to
assess clinical practices, but no other data regarding these practices exist.”
While we
cannot determine what the level of risk associated with each type of needleless
connector based on available evidence, we know we can significantly reduce the known
complications of infection and catheter lumen occlusion by educating our
nursing staff and developing competencies that will increase our skills to use
these needless connectors safely. Healthcare facilities need to establish policies
and procedures that will educate and guide nursing staff on the risk, of not
using these devices correctly and how it may affect patient outcomes.
References
1. Gardner, S. (2012, November 20). Letter to infection control practitioners regarding positive displacement needleless connectors. Retrieved from http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm220459.htm
2. Delahanty KM,
Myers FE III. Nursing2007 infection control survey report Nursing.
2007;37(6):28-36
3. Delahanty KM,
Myers FE III. Nursing2009 I.V. infection control survey report Nursing.
2009;39(12):24-30
4. Hadaway L,
Richardson D. Needleless connectors: a primer on terminology J Infus Nurs.
2010;33(1):22-31